While Realty Income has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

While Bristol-Myers Squibb has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

What do you get when you mix a YouTube-famous cartoon cat, a pixelated frog sidekick, and a shark-dancing troll coin? No, ...

Shares of Regency Centers Corp. REG slipped 1.26% to $71.40 Thursday, on what proved to be an all-around dismal trading ...

This was the stock's third consecutive day of losses.

Big Tech is spending more than ever on artificial intelligence - but the returns are rising too, and investors are buying in.

Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...

On July 21, the S&P 500 closed above its 20-day moving average for 60 straight days. Investors use moving averages to chart ...

Nathan Smith’s AI-built portfolio is up 23.8% in four weeks after leveraging ChatGPT. He shares his take on micro-caps, risk, ...

The expansion will focus on about 100 of the most influential private companies, especially in key sectors like artificial ...

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's ...

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's ...